Acquas E - Search Results

1

New perspective for an old drug: Can naloxone be considered an antioxidant agent?

Migheli R, Lostia G, Galleri G, Rocchitta G, Serra PA, Campesi I, Bassareo V, Acquas E, Peana AT. Migheli R, et al. Among authors: acquas e. Biochem Biophys Rep. 2023 Feb 20;34:101441. doi: 10.1016/j.bbrep.2023.101441. eCollection 2023 Jul. Biochem Biophys Rep. 2023. PMID: 36875795 Free PMC article.

2

Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.

Acquas E, Tanda G, Di Chiara G. Acquas E, et al. Neuropsychopharmacology. 2002 Aug;27(2):182-93. doi: 10.1016/S0893-133X(02)00290-7. Neuropsychopharmacology. 2002. PMID: 12093592

3

The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat.

Acquas E, Day JC, Fibiger HC. Acquas E, et al. Eur J Pharmacol. 1994 Jul 21;260(1):85-7. doi: 10.1016/0014-2999(94)90013-2. Eur J Pharmacol. 1994. PMID: 7957630

4

Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.

Acquas E, Di Chiara G. Acquas E, et al. Eur J Pharmacol. 1999 Oct 27;383(2):121-7. doi: 10.1016/s0014-2999(99)00570-1. Eur J Pharmacol. 1999. PMID: 10585525

5

Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition.

Acquas E, Fibiger HC. Acquas E, et al. J Neurochem. 1998 Mar;70(3):1088-93. doi: 10.1046/j.1471-4159.1998.70031088.x. J Neurochem. 1998. PMID: 9489729 Free article.

6

Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests.

Zernig G, Ahmed SH, Cardinal RN, Morgan D, Acquas E, Foltin RW, Vezina P, Negus SS, Crespo JA, Stöckl P, Grubinger P, Madlung E, Haring C, Kurz M, Saria A. Zernig G, et al. Among authors: acquas e. Pharmacology. 2007;80(2-3):65-119. doi: 10.1159/000103923. Epub 2007 Jun 14. Pharmacology. 2007. PMID: 17570954 Review.

7

Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo.

Acquas E, Marrocu P, Pisanu A, Cadoni C, Zernig G, Saria A, Di Chiara G. Acquas E, et al. Eur J Pharmacol. 2001 Apr 27;418(3):207-11. doi: 10.1016/s0014-2999(01)00937-2. Eur J Pharmacol. 2001. PMID: 11343691

8

Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum.

Acquas E, Di Chiara G. Acquas E, et al. Eur J Pharmacol. 1999 Nov 3;383(3):275-9. doi: 10.1016/s0014-2999(99)00660-3. Eur J Pharmacol. 1999. PMID: 10594319

9

Simultaneous Golgi-Cox and immunofluorescence using confocal microscopy.

Spiga S, Acquas E, Puddu MC, Mulas G, Lintas A, Diana M. Spiga S, et al. Among authors: acquas e. Brain Struct Funct. 2011 Sep;216(3):171-82. doi: 10.1007/s00429-011-0312-2. Epub 2011 Apr 2. Brain Struct Funct. 2011. PMID: 21461741 Free PMC article.

10

Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.

Acquas E, Wilson C, Fibiger HC. Acquas E, et al. J Pharmacol Exp Ther. 1997 Apr;281(1):360-8. J Pharmacol Exp Ther. 1997. PMID: 9103518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters